Skip to main content

Alleviation of Dyspnea in Patients with Advanced Cancer: Usefulness of Opioid

  • Conference paper
Current Perspectives and Future Directions in Palliative Medicine
  • 69 Accesses

Summary

We report two studies to evaluate the effectiveness of systemic opioid as symptomatic treatment of dyspnea in patients with advanced cancer. In the first study, the severity of dyspnea was reduced by at least one grade in 15(71%) of the 21 patients and was not reduced in 6(29%). The average dose of morphine was 32.2 mg. In another study, the protocol was prepared collaboratively by the palliative care team of 2 istitutions. Improvement rates were similar in the 2 institutions; 76% and 68%. We suggest that small starting dose of morphine should be given for dyspnea and then gradually increased. Patients should be advised about side-effect and carefully monitored.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Moore DP, Weston AR, Hughes JMB, et al. (1992) Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure. Lancet 339:850–853

    Article  PubMed  CAS  Google Scholar 

  2. Cohen MH, Johnston Anderson A, Krasnow SH, et al. (1991) Continuous intravenous infusion of morphine for severe dyspnea. South Med J 84: 229–234

    Article  PubMed  CAS  Google Scholar 

  3. Cook DJ, Guyatt GH, Laupacis A, et al. (1992) Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 102: 205S–311S

    Google Scholar 

  4. Bruera E, MacEachern T, Ripamonti C, et al. (1993) Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med 119: 906–907

    PubMed  CAS  Google Scholar 

  5. Bruera E, Macmillan K, Pither J, et al. (1990) The effects of morphine on dyspnea of terminal cancer patients. J Pain Sympt Manag 5:341–344

    Article  CAS  Google Scholar 

  6. Bruera E, Macmillan K, Hanson J, et al. (1989) The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain 39:13–16

    Article  PubMed  CAS  Google Scholar 

  7. Ahmedzai S.(1998) Palliation of respiratory symptoms. In: Doyle D, Hanks GWC, MacDonald RN(eds) Oxford textbook of palliative medicine, 2nd ed. Oxford University Press, Oxford, pp 583–616

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Tokyo

About this paper

Cite this paper

Shima, Y., Saito, R. (1998). Alleviation of Dyspnea in Patients with Advanced Cancer: Usefulness of Opioid. In: Eguchi, K., Klastersky, J., Feld, R. (eds) Current Perspectives and Future Directions in Palliative Medicine. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68494-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68494-7_6

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68496-1

  • Online ISBN: 978-4-431-68494-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics